National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic health

Affiliations

¹ Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford.
² Res Consortium, Andover, UK.
³ Cognitive Behavioural Therapy and Behavioural Medicine, Psychotherapeutic Center of the University of Zurich, The University of Zurich, Zurich, Switzerland.
⁴ Department of Clinical Psychology, Salford Royal Hospital, Salford.
⁵ Faculty of Science and Engineering, Manchester Metropolitan University.
⁶ The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.

Unaiza Waheed et al. Cardiovasc Endocrinol Metab. 2022.

. 2022 Sep 5;11(4):e0270.

doi: 10.1097/XCE.0000000000000270. eCollection 2022 Dec.

¹ Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford.
² Res Consortium, Andover, UK.
³ Cognitive Behavioural Therapy and Behavioural Medicine, Psychotherapeutic Center of the University of Zurich, The University of Zurich, Zurich, Switzerland.
⁴ Department of Clinical Psychology, Salford Royal Hospital, Salford.
⁵ Faculty of Science and Engineering, Manchester Metropolitan University.
⁶ The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.

No abstract available

Conflict of interest statement

There are no conflicts of interest.

1. Heald AH, Stedman M, Davies M, Livingston M, Taylor D, Gadsby R. Antidepressant prescribing in England: patterns and costs. Prim Care Companion CNS Disord 2020; 22:19m02552. - PubMed
1. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 2021; 398:1700–1712. - PMC - PubMed
1. Mansfield KE, Mathur R, Tazare J, Henderson AD, Mulick AR, Carreira H, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digit Health 2021; 3:e217–e230. - PMC - PubMed
1. Jacob L, Smith L, Koyanagi A, Oh H, Tanislav C, Shin JI, et al. Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany. J Psychiatr Res 2021; 143:528–533. - PMC - PubMed
1. Halaris A. Inflammation-associated co-morbidity between depression and cardiovascular disease. Curr Top Behav Neurosci 2017; 31:45–70. - PubMed